Esperion Therap (ESPR) Posts Q1 Loss of 51c/Share

Esperion Therap (NASDAQ: ESPR) reported Q1 EPS of ($0.51), $0.11 better than the analyst estimate of ($0.62).

For earnings history and earnings-related data on Esperion Therap (ESPR) click here.

You May Also Be Interested In

• JPMorgan raises S&P 500 target to 7,800, says earnings revision ’unprecedented’
• Benchmark Reiterates Hold Rating on Old Dominion Freight Line (ODFL) as 'Quality Largely Priced in'
• Virax Biolabs announces 1-for-25 reverse stock split on Nasdaq